Evidence mapPaperPMID 41247440Full record

ArticleProbiotics and antimicrobial proteins2026

Spray-Dried Microencapsulation of Lacticaseibacillus Rhamnosus GG (ATCC 53103) in Cross-Linked Alginate Enriched with Soluble Fiber for Application in Functional Flan and Soup: Viability Assessment during Processing and Storage.

Mariela Bustamante, B Dave Oomah, César Burgos-Díaz, Daniela Vergara, Carolina Shene

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariela BustamanteDepartment of Chemical Engineering, Center of Food Biotechnology and Bioseparations, BIOREN, and Centre of Biotechnology and Bioengineering (CeBiB), Universidad de La Frontera, Temuco, 4811230, Chile. mariela.bustamante@ufrontera.cl.
B Dave OomahSummerland Research and Development Centre, Agriculture and Agri-Food Canada, Summerland, BC, V0H 1Z0, Canada.
César Burgos-DíazAgriaquaculture Nutritional Genomic Center (CGNA), Temuco, Chile.
Daniela VergaraLaboratory of Pharmaceutical and Cosmetic Bioproducts, Center of Excellence in Translational Medicine-Scientific Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco, 4811230, Chile.
Carolina SheneDepartment of Chemical Engineering, Center of Food Biotechnology and Bioseparations, BIOREN, and Centre of Biotechnology and Bioengineering (CeBiB), Universidad de La Frontera, Temuco, 4811230, Chile.

Funding

Agencia Nacional de Investigación y Desarrollo 1211211
6 · The paper itself

Abstract

The development of non-fermented probiotic products in powders requires strategies to ensure their viability and metabolic activity under adverse conditions. In this study, a cross-linked alginate matrix was used to encapsulate Lacticaseibacillus rhamnosus GG (ATCC 53103) using the spray-drying technique. The matrix was supplemented with the following encapsulating agents: chia seed mucilage (CM), flaxseed mucilage (FM) and inulin. Response surface methodology was used to evaluate the effects of the type and concentration of encapsulating agent and CaHPO

Indexed as

AlginatesFlaxLacticaseibacillus rhamnosusProbioticsDesiccationDietary FiberDrug CompoundingFood, ProcessedFood StorageGlucuronic AcidHexuronic AcidsMicrobial ViabilitySpray DryingAlginatesDietary FiberGlucuronic AcidHexuronic AcidsChia seed mucilageCross-linked alginate matricesFlaxseed mucilageLacticaseibacillus Rhamnosus ATCC 53103Lacticaseibacillus Rhamnosus GGProbioticsSpray drying

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.